Inpatient rehab in New York treats adults with substance use disorders across a range of substances and severities. At Elev8 Centers, our licensed inpatient rehab facility in Harlem, New York City, we treat alcohol use disorder, opioid use disorder, stimulant use disorder, polysubstance use, and co-occurring mental health conditions alongside all of these. Every patient receives a personalized treatment plan built around their clinical profile through our reliable inpatient rehab program. To ask about admission or verify your insurance coverage, call us at (646) 347-1891. We accept admissions 24 hours a day, including weekends and holidays.
We are licensed by OASAS, accredited by NAATP, and LegitScript certified. Over 500 adults have received care at our facility at 151 W 136th Street in Harlem.
Alcohol Use Disorder
Alcohol use disorder (AUD) is one of the most common conditions treated in inpatient rehab settings in New York. It is defined by the DSM-5 as a pattern of alcohol use that involves problems controlling intake, continued use despite consequences, and physical dependence.
Alcohol withdrawal is medically serious. Abrupt cessation after heavy, prolonged use can produce seizures and, in severe cases, a condition called delirium tremens. Medical detox for alcohol is not optional. It is a clinical requirement. At our facility, detox is medically supervised 24/7, with medications used to manage withdrawal symptoms and prevent dangerous complications. Detox runs approximately 5 to 6 days, with closer monitoring where alcohol withdrawal carries a higher risk profile.
Following detox, patients transition directly into our inpatient rehabilitation program. Medication-assisted treatment (MAT) for alcohol use disorder, including naltrexone and acamprosate, is available where clinically appropriate.
Opioid Use Disorder
Opioid use disorder (OUD) includes addiction to heroin, prescription opioids such as oxycodone and hydrocodone, and fentanyl. Opioid withdrawal is intensely uncomfortable and, in certain cases, medically serious. Our medically supervised detox program manages opioid withdrawal with 24/7 monitoring and medications to reduce symptoms.
MAT for opioid use disorder uses FDA-approved medications, including buprenorphine and naltrexone, alongside counseling. According to NIDA, MAT significantly reduces opioid use, overdose risk, and treatment dropout. It is a clinical standard of care, not a substitute addiction. Our MAT program is available across appropriate levels of care, from detox through outpatient.
After detox, patients move into our inpatient rehabilitation program, where individual counseling, group therapy, and psychiatric care are structured around the specific behavioral and psychological dimensions of opioid addiction.
Stimulant Use Disorder
Stimulant use disorder covers addiction to cocaine, crack cocaine, methamphetamine, and prescription stimulants such as amphetamines. Stimulant withdrawal does not typically carry the same acute medical risk as alcohol or opioid withdrawal, but the psychological dimensions, including depression, fatigue, and intense cravings, can be severe.
Inpatient rehab is appropriate for adults with stimulant use disorder who have been unable to stop through outpatient support, who are experiencing significant psychiatric symptoms alongside stimulant use, or whose home environment does not support early recovery. Our dual diagnosis program addresses co-occurring depression, anxiety, and PTSD that frequently accompany stimulant use disorder.
Polysubstance Use Disorder
Many adults in treatment are not using a single substance. They are managing dependence on multiple substances at the same time, or shifting between substances. This is classified as polysubstance use disorder and requires a treatment approach that accounts for multiple withdrawal profiles, multiple behavioral patterns, and a higher likelihood of co-occurring psychiatric conditions.
Our inpatient program is equipped to manage polysubstance presentations. The clinical intake assessment identifies all substances involved, and the treatment plan is built around the full picture, not a single-substance protocol applied to a more complex case.
Co-Occurring Mental Health Conditions
Substance use disorder and mental health conditions frequently occur together. According to SAMHSA, roughly half of people with SUD have at least one co-occurring mental health condition. Depression, anxiety disorders, PTSD, bipolar disorder, and trauma are among the most common.
At Elev8 Centers, our dual diagnosis treatment is not a separate program. It is integrated into the standard program at every level of care. Psychiatric evaluation happens at intake. Medication management, mental health counseling, and trauma-informed care are part of the inpatient program, PHP, and outpatient programs. Patients do not have to complete addiction treatment before getting psychiatric help. Both are addressed from the start.
Treating only the substance use without addressing the mental health condition is one of the most common reasons treatment does not hold. Our approach addresses both because the evidence supports doing so.
All Programs Are Available Across All These Conditions
Regardless of the substance or conditions being treated, our full continuum of care is available at the same facility. Medical detox, inpatient rehabilitation, residential treatment, PHP, outpatient programs, dual diagnosis treatment, and MAT all operate under one roof at 151 W 136th Street in Harlem.
Patients do not transfer facilities as their clinical needs change. The same clinical team supports them from detox through discharge.
Insurance and Admissions
We accept most Medicaid plans and some commercial insurance plans across all programs. Our admissions team verifies coverage before your first visit. To check your coverage and begin the admissions process, call us at (646) 347-1891.
Related Topics:
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.jpg)
